Efficacy and safety of calcineurin inhibitor treatment for IgA nephropathy: a meta-analysis

BACKGROUND: IgA nephropathy is the most common progressive glomerular disease to end stage renal failure worldwide. Calcineurin inhibitors (CNIs) is a selective immunosuppressant widely used in organ transplantation. The efficacy and safety of calcineurin inhibitors for the treatment of IgA nephropa...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yu-Huan, Cai, Guang-Yan, Xiao, Yue-Fei, Wang, Yi-Ping, Yuan, Bao-Shi, Xia, Yuan-Yuan, Wang, Si-Yang, Chen, Pu, Liu, Shu-Wen, Chen, Xiang-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307812/
https://www.ncbi.nlm.nih.gov/pubmed/28193247
http://dx.doi.org/10.1186/s12882-017-0467-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307812/
https://www.ncbi.nlm.nih.gov/pubmed/28193247
http://dx.doi.org/10.1186/s12882-017-0467-z

Ejemplares similares